Suppr超能文献

相似文献

1
Targeted therapies and non-small-cell lung cancer: new developments.
Curr Opin Oncol. 2007 Mar;19(2):75-7. doi: 10.1097/CCO.0b013e328012a05b.
2
Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Curr Opin Oncol. 2007 Mar;19(2):98-102. doi: 10.1097/CCO.0b013e328011beec.
3
Targeted therapies and non-small-cell lung cancer: work in progress?
Curr Opin Oncol. 2006 Mar;18(2):132-4. doi: 10.1097/01.cco.0000208785.14818.4b.
5
Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.
Oncologist. 2009 Apr;14(4):399-411. doi: 10.1634/theoncologist.2008-0276. Epub 2009 Apr 8.
6
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
Clin Lung Cancer. 2010 Sep 1;11(5):311-9. doi: 10.3816/CLC.2010.n.039.
8
Targeted therapy for non-small cell lung cancer.
Semin Thorac Cardiovasc Surg. 2005 Fall;17(3):199-204. doi: 10.1053/j.semtcvs.2005.08.001.
9
Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancer.
Cancer Treat Rev. 2011 Dec;37(8):611-7. doi: 10.1016/j.ctrv.2011.04.003. Epub 2011 Jun 8.
10
Developing targeted therapies for lung cancer.
Clin Adv Hematol Oncol. 2003 Nov;1(11):648-9, 690.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验